Pharmacokinetic Bioequivalence of ATI-0918 and DOXIL®/CAELYX® in Patients with Ovarian Cancer
Objective
To assess the pharmacokinetic (PK) bioequivalence of ATI-0918 (test product) and DOXIL®/CAELYX® (reference product).
![](https://www.bioagilytix.com/wp-content/uploads/2022/11/pk_bioequivalence-of-ATI-0918_thumb.jpg)
Objective
To assess the pharmacokinetic (PK) bioequivalence of ATI-0918 (test product) and DOXIL®/CAELYX® (reference product).